Hologic, Inc. (NASDAQ:HOLX) is at least 19.52% than its current record low price of $35.10. There was a 0.91% gain on 07/12/2018 that led the price to move at $41.95. At recent session, the prices were hovering between $41.53 and $42.21. This company shares are 3.31% off its target price of $43.34 and the current market capitalization stands at $11.62B. The recent change has given its price a 7.47% lead over SMA 50 and -7.96% deficit over its 52-week high. The stock witnessed 8.17% gains, 13.23% gains and -3.7% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found HOLX’s volatility during a week at 1.49% and during a month it has been found around 2.03%.Hologic, Inc. (HOLX) Top Holders
Institutional investors currently hold around $11.53 billion or 0% in HOLX stock. Look at its top three institutional owners. Price T Rowe Associates Inc /Md/ owns $1.97 billion in Hologic, Inc., which represents roughly 16.98% of the company’s market cap and approximately 17.11% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 28,109,137 shares of the stock are valued at $1.17 billion. The third largest holder is Capital World Investors, which currently holds $1.05 billion worth of this stock and that ownership represents nearly 9% of its market capitalization.
At the end of March reporting period, 212 institutional holders increased their position in Hologic, Inc. (NASDAQ:HOLX) by some 27,170,480 shares, 226 decreased positions by 20,253,420 and 85 held positions by 229,982,444. That puts total institutional holdings at 277,406,344 shares, according to SEC filings. The stock grabbed 60 new institutional investments totaling 4,831,061 shares while 61 institutional investors sold out their entire positions totaling 3,205,424 shares.Hologic, Inc. (NASDAQ:HOLX) Insider Trades
Multiple company employees have indulged in significant insider trading. Hologic, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Division Pres., Breast Health Valenti Peter J. Iii has sold 10,107 shares of Hologic, Inc. (HOLX) in trading session dated May. 29, 2018. These shares are worth $389,322 and were traded at $38.52 each. The SEC filing shows that Oberton Karleen Marie performed a sale of 12,196 shares. The Corp. VP & Chief Acctg Officer disposed these shares by way of transaction on May. 02, 2018. The company’s shares were given away at $40 per share worth to an income of some $487,840 on account of Oberton Karleen Marie.
SVP, Human Resources, Bebo Allison P, sold 7,000 common shares of Hologic, Inc. (HOLX) in the open market. In a transaction dated Mar. 16, 2018, the shares were put up for sale at an average price of $38.75, raking in a sum of $271,250. After this sale, 21,406 common shares of HOLX are directly owned by the insider, with total stake valued at $897,982.
In the transaction dated Mar. 15, 2018, the great number of shares acquired came courtesy the Director; Dockendorff Charles J added a total of 13,000 shares at an average price of $38.8, amounting to approximately $504,400. The insider now directly owns 17,776 shares worth $745,703.
Several analysts have released their opinion on Hologic, Inc. (NASDAQ:HOLX), with 8 analysts believing it is a strong buy. Whereas 7 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.94 average brokerage recommendation.